@FierceBiotech: EuroBiotech Report: Novartis makes Israel a priority, U.K. dreams up Alzheimer's R&D hub, Shire defends tax model. More | Follow @FierceBiotech
@JohnCFierce: ICYMI: I love this Pronutria story. VC insiders, star scientist, homeostasis focus on oral biologics. It's what makes Boston/Cambridge special. Article | Follow @JohnCFierce
@DamianFierce: Cerecor is repurposing an old $LLY antidepressant for addiction. Release | Follow @DamianFierce
> 23andMe finally convinced the FDA to let it market its genetic test straight to consumers, as the agency cleared the Personal Genome Service as a screen for the rare Bloom syndrome. News
> Thanks to his company's pending merger with Ranbaxy, Sun Pharmaceutical founder Dilip Shanghvi is set to become the richest man in India. More
Medical Device News
@FierceMedDev: Integra LifeSciences lays off 49 in Massachusetts as part of facility consolidation drive. Article | Follow @FierceMedDev
@VarunSaxena2: UPDATED w/ $GE response GE recalls 10,000+ MRI systems after FDA deems them potentially deadly, citing poor training. Article | Follow @VarunSaxena2
@EmilyWFierce: Check out our weekly roundup of FierceLifeSciences news here! Newsletter | Follow @EmilyWFierce
> KKR-backed Panasonic Healthcare to buy Bayer diabetes device biz for as much as $2.3B. More
> 23andMe nabs FDA marketing clearance for direct-to-consumer genetic carrier test. Story
> New studies shed light on power morcellator devices in surgical procedures. Article
Pharma News
@FiercePharma: Sanofi names Paris-trained Olivier Brandicourt CEO. He will begin at Sanofi April 2. Report | Follow @FiercePharma
@CarlyHFierce: ICYMI earlier: Protein Sciences halts Connecticut expansion in response to governor's use of rival flu shot. FierceVaccines story | Follow @CarlyHFierce
> Valeant closing in on $160-per-share Salix deal: Reuters. More
> Ex-Merck analyst pleads guilty to insider trading. Item
> Sanofi makes it official--Brandicourt is its man. Report